Mai Capital Management Eli Lilly & CO Put Options Transaction History

Mai Capital Management

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $289,948 - $363,616	-400 Reduced 8.33%	4,400 $3.98 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $1.6 Million - $2.14 Million	2,700 Added 128.57%	4,800 $3.73 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $32,155 - $37,467	-100 Reduced 4.55%	2,100 $768,000
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $613,206 - $719,994	2,200 New	2,200 $713,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.